These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 1653841

  • 1. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
    Bakry N, Kamata Y, Simpson LL.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
    [Abstract] [Full Text] [Related]

  • 2. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
    [Abstract] [Full Text] [Related]

  • 5. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
    Bakry N, Kamata Y, Sorensen R, Simpson LL.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):613-9. PubMed ID: 1865360
    [Abstract] [Full Text] [Related]

  • 6. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL, Dasgupta BR.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [Abstract] [Full Text] [Related]

  • 7. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
    Simpson LL.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
    [Abstract] [Full Text] [Related]

  • 8. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
    [Abstract] [Full Text] [Related]

  • 9. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA, Bakry N, Zhang RD, Carlson J, Gomella LG, Simpson LL.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [Abstract] [Full Text] [Related]

  • 10. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M, Schulze S, Strotmeier J, Mahrhold S, Richter K, Binz T, Bigalke H, Ahnert-Hilger G, Rummel A.
    Toxicon; 2013 Dec 01; 75():108-21. PubMed ID: 23817019
    [Abstract] [Full Text] [Related]

  • 11. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL.
    J Pharmacol Exp Ther; 1982 Jul 01; 222(1):43-8. PubMed ID: 6283072
    [Abstract] [Full Text] [Related]

  • 12. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S, Coffield JA.
    J Pharmacol Exp Ther; 2001 Mar 01; 296(3):980-6. PubMed ID: 11181932
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin and tetanus toxin recognize similar membrane determinants.
    Simpson LL.
    Brain Res; 1984 Jul 02; 305(1):177-80. PubMed ID: 6331597
    [Abstract] [Full Text] [Related]

  • 14. Role of protein kinase C in short-term transmission at the mammalian neuromuscular junction.
    Considine RV, Sherwin JR, Simpson LL.
    J Pharmacol Exp Ther; 1992 Dec 02; 263(3):1269-74. PubMed ID: 1335062
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL, Coffield JA, Bakry N.
    J Pharmacol Exp Ther; 1994 Apr 02; 269(1):256-62. PubMed ID: 8169833
    [Abstract] [Full Text] [Related]

  • 16. [Structure and function of botulinum toxin].
    Fujii N.
    Hokkaido Igaku Zasshi; 1995 Jan 02; 70(1):19-28. PubMed ID: 7744367
    [Abstract] [Full Text] [Related]

  • 17. Bacterial neurotoxins--a thousand years later.
    Linial M.
    Isr J Med Sci; 1995 Oct 02; 31(10):591-5. PubMed ID: 7591680
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
    Coffield JA, Bakry NM, Maksymowych AB, Simpson LL.
    J Pharmacol Exp Ther; 1999 Jun 02; 289(3):1509-16. PubMed ID: 10336546
    [Abstract] [Full Text] [Related]

  • 19. Occurrence and distribution of sialic acid residues in developing rat glomerulus: investigations with the Limax flavus and the wheat germ agglutinin.
    Wagner P, Roth J.
    Eur J Cell Biol; 1988 Dec 02; 47(2):259-69. PubMed ID: 3243283
    [Abstract] [Full Text] [Related]

  • 20. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL.
    Infect Immun; 1986 Jun 02; 52(3):858-62. PubMed ID: 3011675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.